On ECHEMI
Home > Drugs > Breast hyperplasia
Breast hyperplasia
Fibrocystic breast disease is the most common breast disease in women, and its incidence ranks first among breast diseases. In recent years, the incidence of the disease has been increasing year by year, and the age of onset is getting younger and younger. Fibrocystic breast disease is the physiological proliferation and incomplete restoration of normal breast lobules, and the normal structure of the breast is disordered. It is a pathological hyperplasia. It is neither an inflammatory nor a tumor disease. It is more common in women aged 30-50, with the peak incidence at 35-40 years old.
  • Site of disease:

    breast
  • Infectious :

    Not contagious
  • Frequent population:

    Women aged 30-50
  • Related symptoms:

    Breast pain nodule cyst premenstrual breast pain axillary pain
  • Concurrent disease:

Related Drugs
Breast core internal solution
Manufacturer:

Jilin Yinnuoke Pharmaceutical Co., Ltd.

Breast core internal solution
Manufacturer:

Wuhan Tiantian Jinlong Pharmaceutical Co., Ltd.

Tamoxifen Citrate Tablets
Indication: 1. To treat recurrent and metastatic breast cancer in women. 2. To be used as an adjuvant therapy for metastatic breast cancer after surgery to prevent recurrence.
Tamoxifen Citrate Tablets
Indication: 1. To treat recurrent and metastatic breast cancer in women; 2. To be used as an adjuvant treatment for metastatic breast cancer after surgery to prevent recurrence.
Manufacturer:

Fuan Pharmaceutical Group Ningbo Team Pharmaceutical Co., Ltd.

Rupishu Tablets
Manufacturer:

Changchun Haiwai Pharmaceutical Group Co., Ltd.

Rupishu Tablets
Manufacturer:

Sichuan Senke Pharmaceutical Co., Ltd.

Rupikang Capsules
Manufacturer:

Guangzhou Nuojin Pharmaceutical Co., Ltd.

Prunella Vulgaris Paste
Manufacturer:

Tong Ren Tang Technologies Co., Ltd.

Ru Ning Granules (Sugar-free)
Manufacturer:

Nanjing Tongrentang Pharmaceutical Co., Ltd.

3 Silver breast patch
Indication: This product is used to relieve breast pain and discomfort caused by breast hyperplasia, acute and chronic mastitis, and breast fibroids.
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.